Relative role of insulin resistance and β-cell dysfunction in the progression to type 2 diabetes - The Kinmen Study

Diabetes Research and Clinical Practice

Volumn 59, Issue 3, 2003, Pages 225-232

  Li, Chia Lin ^a   Tsai, Shih Tzer ^b   Chou, Pesus ^c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cell dysfunction; Impaired fasting glucose; Impaired glucose tolerance; Insulin resistance

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; BODY SIZE; CELL FUNCTION; CONTROLLED STUDY; DIET RESTRICTION; DISEASE COURSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HAZARD ASSESSMENT; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; INCIDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; RISK ASSESSMENT; TAIWAN; WORLD HEALTH ORGANIZATION;

BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FASTING; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INCIDENCE; INSULIN RESISTANCE; ISLETS OF LANGERHANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 0037365584     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(02)00249-8     Document Type: Article

References (28)

1. Barbara R.H., Steven E. The natural history of type 2 diabetes-Implications for clinical practice. Primary Care. 26:1999;771-789.
2. Haffner S.M., Miettinen H., Gaskill S.P., Stern M.P. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes. 44:1995;1386-1391.
3. Haffner S.M., D'Agostino R., Saad M.F., et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites - The Insulin Resistance Atherosclerosis Study. Diabetes. 45:1996;742-748.
4. DeFronzo R.A. Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: a balanced overview. Diabetologia. 35:1992;389-397.
5. Hales C.N., Barker D.J.P. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 35:1992;595-601.
6. Temple R.C., Carrington C.A., Luzio S.D., et al. Insulin deficiency in non-insulin-dependent diabetes. Lancet. i:1989;293-295.
7. National Diabetes Data Group, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance, Diabetes 28 (1979) 1039-57.
8. World Health Organization, Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Organization, 1985 (Tech. Rep. Ser., no. 727).
9. Alberti K.G. Impaired glucose tolerance: fact or fiction. Diabet. Med. 13:1996;S6-S8.
10. Saad M.F., Knowler W.C., Pettitt D.J., Nelson R.G., Mott D.M., Bennett P.H. The natural history of impaired glucose tolerance in the Pima Indians. N. Engl. J. Med. 319:1988;1500-1506.
11. O'Rahilly S., Hattersley A., Vaag A., Gray H. Insulin resistance as the major cause of impaired glucose tolerance: a self-fulfilling prophesy? Lancet. 344:1994;585-589.
12. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care 20 (1997) 1183-97.
13. Davies M.J., Raymond N.T., Day J.L., Hales C.N., Berden A.C. Impaired glucose tolernace and fasting hyperglycaemia have different characteristics. Diabet. Med. 17:2000;433-440.
14. Mannucci E., Bardini G., Ognibene A., Rotella C.M. Comparison of ADA and WHO screening methods for diabetes mellitus in obese patients. Diabet. Med. 16:1999;579-585.
15. World Health Organization, Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva, World Health Organization, 1999.
16. Li C.L., Tsai S.T., Chou P. Comparison of the results between two dignostic criteria by ADA and WHO among subjects with FPG 5.6-7.8 mmol/l in Kin-Hu and Kin-Chen, Kinmen, 1991-94. Diabets Res. Clin. Pract. 45:1999;51-59.
17. Li C.L., Tsai S.T., Chou P. Comparison of metabolic risk profiles between subjects with fasting and 2-h plasma glucose impairment - The Kinmen Study. J. Clin. Epidemiol. 55:2002;19-24.
18. Tsai S.T., Li C.L., Chen C.H., Chou P. Community-based epidemiological study of glucose tolerance in Kin-Chen, Kinmen: support for a new intermediate classification. J. Clin. Epidemiol. 53:2000;505-510.
19. Chou P., Li C.L., Wu G.S., Tsai S.T. Progression to type 2 diabetes among high-risk groups in Kin-Chen, Kinmen - exploring the natural history of type 2 diabetes. Diabetes Care. 21:1998;1183-1187.
20. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.L. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419.
21. Hanefeld M., Koehler C., Henkel E., Fuecker K., Schaper F., Temelkova-Kurktschiev T. Post-challenge hyperglycaemia related more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study. Diabet. Med. 17:2000;835-840.
22. Haffner S.M., Gonzalez C., Miettinen H., Kennedy E., Stern M.P. A prospective analyses of the HOMA model: the Mexico City Diabetes Study. Diabetes Care. 19:1996;1138-1141.
23. Haffner S.M., Miettinen H., Stern M.P. The Homeostatis model in the San Antonio Heart Study. Diabetes Care. 20:1997;1087-1092.
24. Kim D.J., Lee M.S., Kim K.W., Lee M.K. Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus. Metabolism. 50:2001;590-593.
25. Tripathy D., Carlsson M., Almgren P., et al. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia study. Diabetes. 49:2000;975-980.
26. Gabir M.M., Hanson R.L., Dabelea D., et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care. 23:2000;1108-1112.
27. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp techniques: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237:1979;E214-E223.
28. Shen D.C., Shieh S.M., Fuh M.M.T., Wu D.A., Chen Y.D.I., Reaven G.M. Resistance to insulin stimulated glucose uptake in patients with hypertension. J. Clin. Endocrinol. Metab. 66:1988;580-583.